70OA phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumorsS Deva, J-S Lee,C-C Lin,C-J Yen,M Millward,Y Chao,B Keam,M Jameson,M-M Hou,Y-K Kang,B Markman,C-H Lu,K-M Rau,K-H Lee,L Horvath,M Friedlander,A Hill,J Wu,J Hou,J DesaiAnnals of Oncology(2018)引用 19|浏览28暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要